ABOUT US

​

Armstead Industries is a Private Equity Group that Joint Ventures with and buys income producing profitable businesses.

We are geographically agnostic.  Please contact us to schedule a presentation. 

​

Joint Venture OR Business Sale!

​

JOINT VENTURE

Many business owners are seeking capital to grow but do not want the burden of debt.  We will enter into a Joint Venture with you whereby we buy 10% to 90% of your business.  The sale of the equity is based upon verified profit and use of our capital injection for projected growth via a strategic acquisition or sound marketing and operations growth plan.  

 

BUSINESS SALE

You want to retire or have another opportunity you would like to take advantage of in the near future or immediately.  You have listed your business for sale or may have not considered selling until you heard about us.  Businesses are typically sold for 3x - 6x verifiable profit.  

​

Why Us?

- Receive the capital you need and keep an agreed upon ownership stake in your company via a Joint Venture.

- Sell 100% of your business and vacate or stay on as a well paid General Manager.

​

​

Board of Directors:

Thomas Armstead
CEO & CHAIR
Tom is recognized as one of the top real estate and business financing experts in the country. He has worked and consulted for hundreds of companies including Deutsche Bank.

Simone Sloan, Rph MBA
Simone is an experienced executive strategist and coach. She is an author and consultant for many Fortune 500 Companies.

Steve Duke
Steve has served as Director of Operations for the franchisor Aamco Transmissions, Inc. He has also served as Vice President of Operations, Merchandising and Integration for Floor Coverings International.

Andre Fox Wilson Sr.
Former investment banker for Prudential and financing agent.


Armstead Assisted Living Facilities
Board of Directors:

Marvin L. Storm
Board Chair
40 years of M&A experience.

Lawrence Katz, LPN
CEO
Skilled in Healthcare Operational Optimization, Quality Assurance and Regulatory Compliance


Armstead Medical Practices
Board of Directors :

Thomas Armstead
CEO & CHAIR

Mark Lepore MD, FAAAAI
Chief Medical Officer, Allergy at Aquestive Therapeutics. Prior to joining Aquestive, Dr. Lepore was the Vice President of Global Clinical Strategy and Development for Lupin. He held various roles at Teva, where he helped develop several device products.

Ian Leber, MD, MBA, CPE, FACEP
Ian is currently the CMO at Sollis Health Care. He has experience in Emergency Medicine and hospital operations.

​

​

COPYRIGHT 2020 ARMSTEAD INDUSTRIES INC.  ALL RIGHTS RESERVED.